Zenotech Laboratories Ltd Financials
Company Logo

Zenotech Laboratories Ltd Financial Statement

Zenotech Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue11.46
Operating Expense7.36
Net Profit1.35
Net Profit Margin11.78
Earning Per Share0.22
EBIDTA3.10
Effective Tax RateTBA

Zenotech Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual40.83
Operating Expenses Annual23.61
Operating Profit Annual18.23
Interest AnnualTBA
Depreciation7.09
Net Profit Annual8.30
Tax Annual2.84

Zenotech Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning11.14
Cash Flow from Operations11.82
Cash Flow from Investing-21.15
Cash Flow from FinancingTBA
Cash Flow at the End1.82

Zenotech Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)44.65
PBIT Margin (%)27.28
PBT Margin (%)27.28
Net PROFIT Margin (%)20.33
Return On Networth / Equity (%)3.07
Return On Networth /Employed (%)4.09
Return On Assets (%)9.35
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.46

Zenotech Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual65.58
Total Current Assets Annual26.16
Non Current Assets Annual80.04
Total Shareholders Funds Annual90.54
Total Assets Annual106.21

Zenotech Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 22, 2024, Zenotech Laboratories Ltd has a market capitalization of 360.75 Cr. Value Research classifies it as a Small-Cap company.
Yes, Zenotech Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Zenotech Laboratories Ltd recorded a total revenue of approximately 36.76 Cr marking a significant milestone in the company's financial performance.
Zenotech Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.1% annually, respectively..
Zenotech Laboratories Ltd's current PE ratio is 43.46.
Zenotech Laboratories Ltd's ROCE averaged 14.7% from the FY ending March 2022 to 2024, with a median of 14.3%. It peaked at 17.6% in March 2023, reflecting strong capital efficiency over the period..
Zenotech Laboratories Ltd's latest EBIT is Rs. 11.14 Cr, surpassing the average EBIT of Rs. 12.29 Cr over the 5 years..

Built for those who know the

game inside-out.

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions